NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or “the Company”) is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure, LLC. The Agreement gives Cascade Pure the exclusive right to produce and distribute Evolve Formulas products in the State of Oregon.

NanoSphere Health Science’s cannabis line, Evolve Formulas, utilizes a patented method of nano-encapsulating cannabis molecules in a lipid membrane so they can be transported through the skin or mucosa to the bloodstream in minutes. Evolve products are currently available in dispensaries across Colorado and are coming soon in California, Arizona, Oklahoma, Canada and Mexico.

“Our Company’s strategy is to partner with cannabis producers who are dedicated to an exceptionally high, pharmaceutical-grade standard of production,” said NanoSphere CEO Robert Sutton. “Cascade Pure is a perfect fit for us, as they are building a state-of-the-art facility, and are very much a science-based company developing science-based solutions.”

The Cascade Pure facility is being completed in Bend, Oregon, and features a vertical farming system developed by Smart Grow Systems ( Cascade Pure is also acquiring the rights to a top quality genetics (seed) library, which Sutton says will help NanoSphere develop new cannabinoid product lines in future.

Cascade Pure CEO Edward Bonn says the NanoSphere agreement is a cornerstone of his company’s growth strategy in the Oregon market.

“There are a lot of producers generating an over-supply of cannabis in the Oregon market, which puts downward pressure on prices over the long term,” Bonn says. “NanoSphere’s Evolve Formulas patented products are fully developed, completely unique in the global market, and are very difficult for anyone else to reproduce. This gives us a huge advantage in the market and separates us from the crowd as the exclusive supplier of Evolve products.”

NanoSphere has developed three next generation nanoparticle delivery platforms. The first is a transdermal serum that can be applied to the skin to treat pain and inflammation in the joints and muscles and which does not have a psychoactive effect on the user.

The second is an intraoral product that allows cannabis to penetrate the mucosal membrane in the mouth for delivery directly to the bloodstream, providing much faster onset, precise dosing, and an effect closer to that of smoking or vaping.

The third is an intranasal spray that delivers cannabinoid nanoparticles, or ‘nanospheres’, directly to the brain via the transgeminal nerve. The Evolve spray provides virtually instant onset and very precise dosing for both medical and recreational use.

“There is no other way I know of to get the full entourage effect of cannabinoids and terpenes without smoking or vaping, but NanoSphere has solved that problem with a product that is unique in the market,” said Bonn. “This is a truly disruptive technology, and we will be the sole provider of that technology in Oregon.”

Under the agreement, Cascade Pure and NanoSphere will each receive 50 percent of the gross profit from the sale of Evolve Formulas products. The initial term of the agreement is 36 months, and is automatically renewable barring a significant breach of the Agreement by either party.

About NanoSphere

NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the bio delivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. For more information on NanoSphere, please visit

About Evolve Formulas

Evolve Formulas is the provider of the world’s first and only scientifically proven nanoparticle delivery system in cannabis. Evolve’s pioneering product, Transdermal NanoSerum™, is a fast acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. For more information on Evolve Formulas, visit Follow us on FacebookInstagram and Twitter.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Forward Looking Statement Caution

This news release includes forward-looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company’s intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company’s future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Without limitation, these include assumptions, risks and uncertainties inherent in completing sub-licensing arrangements in the United States, Canada and abroad, product demand, production, competition and government regulation of the Cannabis industry, any and all of which may have an adverse effect on the Company’s expansion plans, sales, revenues and its financial results and condition. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.


On behalf of the Board
Robert Sutton, CEO
Office: (720) 845-1465

Victor Goncalves, Executive Vice President
Mobile: 204-997-5517

Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an Investor Presentation. 


As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact, or

Keep reading... Show less